Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles A Schiffer

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Haematology|March 6, 2007
Myelodysplasia: the good, the fair and the uglyCharles A Schiffer
Seminars in Hematology|January 9, 2008
World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromesCharles A Schiffer
Hematology. American Society of Hematology. Education Program|November 25, 2006
Clinical issues in the management of patients with myelodysplasiaCharles A Schiffer
Best Practice & Research. Clinical Haematology|December 2, 2008
Molecular characterization of AML: a significant advance or just another prognostic factor?Charles A Schiffer
Best Practice & Research. Clinical Haematology|December 3, 2014
Optimal dose and schedule of consolidation in AML: is there a standard?Charles A Schiffer
Medical Mycology|November 10, 2018
Granulocyte transfusion therapy 2006: The comeback kid?Charles A Schiffer
Current Hematologic Malignancy Reports|April 29, 2010
Molecular monitoring of BCR-ABL transcripts in patients with chronic myelogenous leukemia: is high sensitivity of clinical value?Maxim Norkin, Charles A Schiffer
Expert Opinion on Pharmacotherapy|June 24, 2008
Current treatment options and strategies for myelodysplastic syndromesSridhar Srinivasan, Charles A Schiffer
Expert Review of Hematology|February 16, 2016
The artful management of older patients with acute myeloid leukemiaJay Yang, Charles A Schiffer
Infectious Disease Clinics of North America|May 24, 2020
Infectious Complications of Tyrosine Kinase Inhibitors in Hematological MalignanciesAndrew Kin, Charles A Schiffer
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Haematology|March 6, 2007
Myelodysplasia: the good, the fair and the uglyCharles A Schiffer
Seminars in Hematology|January 9, 2008
World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromesCharles A Schiffer
Hematology. American Society of Hematology. Education Program|November 25, 2006
Clinical issues in the management of patients with myelodysplasiaCharles A Schiffer
Best Practice & Research. Clinical Haematology|December 2, 2008
Molecular characterization of AML: a significant advance or just another prognostic factor?Charles A Schiffer
Best Practice & Research. Clinical Haematology|December 3, 2014
Optimal dose and schedule of consolidation in AML: is there a standard?Charles A Schiffer
Medical Mycology|November 10, 2018
Granulocyte transfusion therapy 2006: The comeback kid?Charles A Schiffer
Current Hematologic Malignancy Reports|April 29, 2010
Molecular monitoring of BCR-ABL transcripts in patients with chronic myelogenous leukemia: is high sensitivity of clinical value?Maxim Norkin, Charles A Schiffer
Expert Opinion on Pharmacotherapy|June 24, 2008
Current treatment options and strategies for myelodysplastic syndromesSridhar Srinivasan, Charles A Schiffer
Expert Review of Hematology|February 16, 2016
The artful management of older patients with acute myeloid leukemiaJay Yang, Charles A Schiffer
Infectious Disease Clinics of North America|May 24, 2020
Infectious Complications of Tyrosine Kinase Inhibitors in Hematological MalignanciesAndrew Kin, Charles A Schiffer
Pageof 9